Two of the main affected genes in pancreatic cancer according to TCGA, KRAS (75.27%) and TP53 (62.64%), were also found in similar proportions in our validation cohort, being 75.00% and 66.67% respectively. This evidence concerns the gene KRAS and familial pancreatic carcinoma.